Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation
Hee Won Yang,
Steven D Cappell,
Ariel Jaimovich,
Chad Liu,
Mingyu Chung,
Leighton H Daigh,
Lindsey R Pack,
Yilin Fan,
Sergi Regot,
Markus Covert,
Tobias Meyer
Affiliations
Hee Won Yang
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, United States
Steven D Cappell
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, United States
Ariel Jaimovich
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
Chad Liu
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
Mingyu Chung
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
Leighton H Daigh
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
Lindsey R Pack
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
Yilin Fan
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States
Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, United States; Department of Bioengineering, Stanford University School of Medicine, Stanford, United States
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States; Department of Bioengineering, Stanford University School of Medicine, Stanford, United States
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States; Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, United States
Mammalian cells typically start the cell-cycle entry program by activating cyclin-dependent protein kinase 4/6 (CDK4/6). CDK4/6 activity is clinically relevant as mutations, deletions, and amplifications that increase CDK4/6 activity contribute to the progression of many cancers. However, when CDK4/6 is activated relative to CDK2 remained incompletely understood. Here, we developed a reporter system to simultaneously monitor CDK4/6 and CDK2 activities in single cells and found that CDK4/6 activity increases rapidly before CDK2 activity gradually increases, and that CDK4/6 activity can be active after mitosis or inactive for variable time periods. Markedly, stress signals in G1 can rapidly inactivate CDK4/6 to return cells to quiescence but with reduced probability as cells approach S phase. Together, our study reveals a regulation of G1 length by temporary inactivation of CDK4/6 activity after mitosis, and a progressively increasing persistence in CDK4/6 activity that restricts cells from returning to quiescence as cells approach S phase.